Covance, Inc. (NYSE:CVD)
CAPS Rating:
A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.
RSS Headlines
Fool UK
Recs
Showed up on a screen for solid 5 year growth with low debt, cash on hand and still at attractive P/E ratios.